跳至主要内容
临床试验/IRCT20121216011763N61
IRCT20121216011763N61尚未招募3 期

Evaluation the effect of saffron supplementation on inflammatory indices, antioxidant status, cilinical signs, mental health, intestinal permeability, quality of life, and sleep quality in patients with Parkinson's disease: A triple blind randomized controlled clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 80 years(—)
性别
All

入选标准

  • Agreement for participation in the study
  • Age of 50 to 80 years old
  • Diagnosis of Parkinson's disease based on United Kingdom PD Society Brain Bank (UKPDSBB) criteria
  • Having the Hoehn and Yahr score less than 5
  • BMI equal or less than 35

排除标准

  • Adherence to a specific diet or consumption of antioxidant supplements in the last 3 months
  • Patients with other neurodegenerative diseases such as Huntington's disease, Wilson's disease
  • Central nervous system infections such as meningitis
  • Having a Hoehn and Yahr score of 5 out of 5
  • Patients with a history of saffron allergy

研究者

相似试验